Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-052203
Filing Date
2018-09-25
Accepted
2018-09-25 18:36:35
Documents
1
Period of Report
2018-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4588
  Complete submission text file 0001209191-18-052203.txt   6259
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE 110 POINT RICHMOND CA 94804
Business Address
Kennedy Joseph T (Reporting) CIK: 0001408920 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 181086548